RxDoctor Payments DataLook up a doctor →

Harold Dauerman, MD

Cardiovascular Disease · Burlington, VTNPI 1760494272

Payments from drug & device makers

$1,398,731in general payments, 2019–2025

Across 473 payments — averaging $2957.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$799K
  • Medtronic$571K
  • Edwards Lifesciences$16K
  • Abbott$5K
  • Bayer$5K
  • Abiomed$3K
$14,156in research payments, 2019–2025

Across 24 payments — averaging $589.84 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$14K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Boston Scientific137$799,419
Medtronic(2 entities)306$570,733
Edwards Lifesciences20$15,750
Abbott5$5,100
Bayer3$4,719
Abiomed2$3,010

How this compares

$1,398,731 in reported general payments places this provider in the 95th percentile of 27 cardiovascular disease providers in Vermont.

See all cardiovascular disease providers in Vermont

Medicare billing

Part B allowed, 2024
$83,624
Medicare patients
195
Services billed
321

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other cardiovascular disease in Burlington

See the full list for Vermont

Where these figures come from

Is this you, or does something look wrong? →